IGF1R and neoplasm: It is important in future studies to include anti-IGF1R antibodies, such as A12 (Wu et al, 2005; Rowinsky et al, 2007), which recognise both human and mouse IGF1R, to examine the tumour-to-background signal ratio from regions of interest in tumour and normal tissue.